Coya Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Coya Therapeutics, Inc. (COYA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $103.37 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-03-16
- Coya Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $103.37K, a 2.46% increase from fiscal 2024.
- Coya Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $100.88K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2025-12-31 | $103.37K 10-K · filed 2026-03-16 |
| 2024-12-31 | $100.88K 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |